Avastin / Irinotecan in patients with recurrent or progressive malignant glioma An academic prospective single-arm phase II clinical trial for evaluation of advanced functional neuroimaging techniques and molecular markers in the course of anti-angiogenic therapies in malignant gliomas.

Trial Profile

Avastin / Irinotecan in patients with recurrent or progressive malignant glioma An academic prospective single-arm phase II clinical trial for evaluation of advanced functional neuroimaging techniques and molecular markers in the course of anti-angiogenic therapies in malignant gliomas.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Bevacizumab (Primary) ; Irinotecan (Primary)
  • Indications Glioma
  • Focus Biomarker; Therapeutic Use
  • Acronyms AVIRMA; AVIRMA01-09
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 19 Jul 2016 Status changed from recruiting to completed.
    • 22 Dec 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2009-015036-15).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top